Apimeds Pharmaceuticals US, Inc.
SEC Filing List
CIK: 0001894525
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| NT 10-Q | Notice under Rule 12b25 of inability to ... | Apimeds Pharmaceuticals Us, Inc. | 05/15/2026 | ||
| SCHEDULE 13D/A | 05/07/2026 | ||||
| 8-K | Current report filing | Apimeds Pharmaceuticals Us, Inc. | 05/05/2026 | ||
| 8-K | Current report filing | Apimeds Pharmaceuticals Us, Inc. | 05/04/2026 | ||
| 10-K | Annual report pursuant to Section 13 and... | Apimeds Pharmaceuticals Us, Inc. | 05/04/2026 | ||
| 8-K | Current report filing | Apimeds Pharmaceuticals Us, Inc. | 04/22/2026 | ||
| 8-K | Current report filing | Apimeds Pharmaceuticals Us, Inc. | 04/16/2026 | ||
| 8-K/A | Amendment to Current report filing | Apimeds Pharmaceuticals Us, Inc. | 04/09/2026 | ||
| 425 | Filing under Securities Act Rule 425 of ... | Apimeds Pharmaceuticals Us, Inc. | 04/09/2026 | ||
| NT 10-K | Notice under Rule 12b25 of inability to ... | Apimeds Pharmaceuticals Us, Inc. | 03/31/2026 | ||
| No record found. | |||||
| Load More | |||||
